464 related articles for article (PubMed ID: 26106328)
1. Mesothelial cells in tissue repair and fibrosis.
Mutsaers SE; Birnie K; Lansley S; Herrick SE; Lim CB; Prêle CM
Front Pharmacol; 2015; 6():113. PubMed ID: 26106328
[TBL] [Abstract][Full Text] [Related]
2. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
Guarino M; Tosoni A; Nebuloni M
Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
[TBL] [Abstract][Full Text] [Related]
3. Matrix regulation of idiopathic pulmonary fibrosis: the role of enzymes.
Clarke DL; Carruthers AM; Mustelin T; Murray LA
Fibrogenesis Tissue Repair; 2013 Nov; 6(1):20. PubMed ID: 24279676
[TBL] [Abstract][Full Text] [Related]
4. Mesothelial cells and peritoneal homeostasis.
Mutsaers SE; Prêle CM; Pengelly S; Herrick SE
Fertil Steril; 2016 Oct; 106(5):1018-1024. PubMed ID: 27692285
[TBL] [Abstract][Full Text] [Related]
5. The pleural mesothelium in development and disease.
Batra H; Antony VB
Front Physiol; 2014; 5():284. PubMed ID: 25136318
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic role of αB-crystallin inhibition in pleural and subpleural fibrosis.
Bellaye PS; Burgy O; Colas J; Fabre A; Marchal-Somme J; Crestani B; Kolb M; Camus P; Garrido C; Bonniaud P
Am J Respir Cell Mol Biol; 2015 Feb; 52(2):244-52. PubMed ID: 25032514
[TBL] [Abstract][Full Text] [Related]
7. Mesothelial Cells Participate in Endometriosis Fibrogenesis Through Platelet-Induced Mesothelial-Mesenchymal Transition.
Yan D; Liu X; Xu H; Guo SW
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32813013
[TBL] [Abstract][Full Text] [Related]
8. Mesothelial progenitor cells and their potential in tissue engineering.
Herrick SE; Mutsaers SE
Int J Biochem Cell Biol; 2004 Apr; 36(4):621-42. PubMed ID: 15010328
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells.
Strippoli R; Benedicto I; Perez Lozano ML; Pellinen T; Sandoval P; Lopez-Cabrera M; del Pozo MA
PLoS One; 2012; 7(2):e31492. PubMed ID: 22384029
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of mesothelial cells.
Mutsaers SE; Wilkosz S
Cancer Treat Res; 2007; 134():1-19. PubMed ID: 17633044
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Fetal, but Not Adult, Pulmonary Mesothelium to Mesenchymal Lineages in Lung Homeostasis and Fibrosis.
von Gise A; Stevens SM; Honor LB; Oh JH; Gao C; Zhou B; Pu WT
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):222-30. PubMed ID: 26121126
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.
Yáñez-Mó M; Lara-Pezzi E; Selgas R; Ramírez-Huesca M; Domínguez-Jiménez C; Jiménez-Heffernan JA; Aguilera A; Sánchez-Tomero JA; Bajo MA; Alvarez V; Castro MA; del Peso G; Cirujeda A; Gamallo C; Sánchez-Madrid F; López-Cabrera M
N Engl J Med; 2003 Jan; 348(5):403-13. PubMed ID: 12556543
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblastic conversion of mesothelial cells.
Yang AH; Chen JY; Lin JK
Kidney Int; 2003 Apr; 63(4):1530-9. PubMed ID: 12631370
[TBL] [Abstract][Full Text] [Related]
14. Active compounds extracted from extra virgin olive oil counteract mesothelial-to-mesenchymal transition of peritoneal mesothelium cells exposed to conventional peritoneal dialysate: in vitro and in vivo evidences.
Lupinacci S; Toteda G; Vizza D; Perri A; Benincasa C; Mollica A; La Russa A; Gigliotti P; Leone F; Lofaro D; Bonofiglio M; Perri E; Bonofiglio R
J Nephrol; 2017 Dec; 30(6):841-850. PubMed ID: 27914030
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
16. Pleural mesothelial cell differentiation and invasion in fibrogenic lung injury.
Zolak JS; Jagirdar R; Surolia R; Karki S; Oliva O; Hock T; Guroji P; Ding Q; Liu RM; Bolisetty S; Agarwal A; Thannickal VJ; Antony VB
Am J Pathol; 2013 Apr; 182(4):1239-47. PubMed ID: 23399488
[TBL] [Abstract][Full Text] [Related]
17. Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis.
Kang DH
Kidney Res Clin Pract; 2020 Jun; 39(2):136-144. PubMed ID: 32576713
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition as a therapeutic target for prevention of ocular tissue fibrosis.
Saika S; Yamanaka O; Flanders KC; Okada Y; Miyamoto T; Sumioka T; Shirai K; Kitano A; Miyazaki K; Tanaka S; Ikeda K
Endocr Metab Immune Disord Drug Targets; 2008 Mar; 8(1):69-76. PubMed ID: 18393925
[TBL] [Abstract][Full Text] [Related]
19. Activated alveolar epithelial cells initiate fibrosis through autocrine and paracrine secretion of connective tissue growth factor.
Yang J; Velikoff M; Canalis E; Horowitz JC; Kim KK
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L786-96. PubMed ID: 24508728
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis.
Mahalanobish S; Saha S; Dutta S; Sil PC
Pharmacol Res; 2020 Feb; 152():104591. PubMed ID: 31837390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
